Related Experiment Video
Updated: Aug 5, 2026

06:31
Erosion Identification in Metacarpophalangeal Joints in Rheumatoid Arthritis using High-Resolution Peripheral Quantitative Computed Tomography
Published on: October 6, 2023
Fragility Score in Radiographic Axial Spondyloarthritis Assessed with Radiofrequency Echographic Multi-Spectrometry
Elena Bischoff1,2, Stoyanka Vladeva1, Nikola Kirilov3
1Department of Health Care, Faculty of Medicine, Trakia University, 6000 Stara Zagora, Bulgaria.
Life (Basel, Switzerland)
|July 28, 2026
Summary
Axial spondyloarthritis patients show higher fracture risk, as indicated by the REMS-derived Fragility Score (FS). This score identifies skeletal fragility in radiographic axSpA (r-axSpA) beyond standard bone density tests.
Area of Science:
- Rheumatology and Osteoporosis Research
- Skeletal Health Assessment
- Inflammatory Disease Complications
Background:
- Axial spondyloarthritis (axSpA) is a chronic inflammatory condition impacting the spine and sacroiliac joints.
- Patients with axSpA face elevated fracture risks due to inflammation, reduced mobility, and treatment side effects.
- Standard bone mineral density (BMD) assessments like DXA may be compromised by spinal structural changes in radiographic axSpA (r-axSpA).
Purpose of the Study:
- To evaluate skeletal fragility in patients with r-axSpA using the Radiofrequency Echographic Multi-Spectrometry (REMS)-derived Fragility Score (FS).
- To compare FS and conventional BMD measurements between r-axSpA patients and healthy controls.
- To determine if REMS-derived FS can detect increased fracture risk in r-axSpA independently of BMD.
Main Methods:
- A cross-sectional study involving 90 patients with r-axSpA and sex-matched healthy controls.
- Clinical assessments and REMS evaluation of lumbar spine and hip BMD, T-scores, and spinal FS were performed.
- Comparison of FS and BMD metrics between the r-axSpA group and the control group.
Main Results:
- Patients with r-axSpA exhibited higher rates of smoking, prior fractures, and inflammatory markers compared to controls.
- No significant differences in BMD or T-scores were found between r-axSpA patients and controls.
- The FS was significantly higher in the r-axSpA group, indicating a greater fracture risk category.
Conclusions:
- REMS-derived FS may offer a valuable tool for assessing skeletal fragility in r-axSpA.
- FS identifies increased fracture risk in r-axSpA patients where conventional BMD measurements might be insufficient.
- Further research is warranted to explore the clinical utility of FS in managing axSpA patients.
